VH032-C4-NH-Boc
VH032-C4-NH-Boc is a versatile E3 ligase ligand engineered for PROTAC drug development applications. Featuring the VH032 moiety, which selectively binds to the von Hippel-Lindau (VHL) E3 ubiquitin ligase complex, this compound incorporates a C4 linker and a Boc-protected amine, allowing for flexible conjugation in the synthesis of VHL-based PROTAC molecules. As a molecular tool for targeted protein degradation, VH032-C4-NH-Boc enables researchers to design bifunctional chimeras that induce the ubiquitination and subsequent proteasomal degradation of disease-associated target proteins for therapeutic discovery and mechanism-of-action studies.
Structure of 2412055-00-4
Assurance
Delivery
Support
* For research and manufacturing use only. Not for human or clinical use.
| Size | Price | Stock | Quantity |
|---|---|---|---|
| -- | $-- | In stock |
Looking for different specifications? Click to request a custom quote!
Capabilities & Facilities
- Comprehensive PROTAC Platform
- Scientific Expertise & Technical Support
- Custom Synthesis & Design Service
- Extensive Product Coverage
- Cutting-Edge Innovation
- Fast Delivery & Global Support
- 24/7 customer service
- 100% quality assurance
Popular Publications Citing BOC Sciences Products
Background Introduction
VH032-C4-NH-Boc is a derivative of the well-established VHL (von Hippel-Lindau) E3 ubiquitin ligase ligand, VH032, with a tert-butyloxycarbonyl (Boc)-protected amino group introduced via a four-carbon linker. The incorporation of Boc protection enhances the compound's stability against premature reactions during synthesis and allows for subsequent functionalization, facilitating the design and synthesis of versatile VHL-based PROTACs (Proteolysis Targeting Chimeras) for targeted protein degradation applications.
Mechanism
VH032-C4-NH-Boc selectively binds to the VHL E3 ubiquitin ligase complex, recruiting it to the proximity of target proteins when incorporated into PROTAC molecules. Once tethered via a suitable linker to a ligand directed against a target protein, VH032-C4-NH-Boc facilitates the formation of a ternary complex, bringing the VHL E3 ligase and the target protein together. This assembly promotes ubiquitination of the target protein, marking it for proteasomal degradation. The Boc-protected amino group ensures stability during chemical handling and can be deprotected as needed for subsequent linker or ligand attachment.
Applications
VH032-C4-NH-Boc is a valuable chemical tool for researchers engineering VHL-based PROTACs and protein degraders. Its applications include:
• Serving as a key intermediate for synthesizing bifunctional small molecules that target disease-related proteins for degradation.• Supporting medicinal chemistry efforts in optimizing linkage strategies and SAR studies for effective PROTAC design.
• Facilitating the development of next-generation VHL ligands for target validation in drug discovery and chemical biology.
• Application in academic and pharmaceutical research to broaden the spectrum of targetable proteins using the ubiquitin-proteasome pathway.
• Consistent batch-to-batch reproducibility with complete QC documentation
• Supplied with COA, MSDS, and analytical data for traceability
• Reliable global shipping with stability-guaranteed packaging
• Dedicated technical support and optional custom synthesis service
• Demonstrates strong binding affinity to CRBN, VHL, or other E3 ligases
• Enables stable E3 ligase recruitment for targeted protein degradation
• Boc-protected amine for easy deprotection and flexible linker modification
• Optimized for high-affinity binding to VHL E3 ligase, enhancing PROTAC efficacy
* Our calculator is based on the following equation:
Concentration (start) x Volume (start) = Concentration (final) x Volume (final)
It is commonly abbreviated as: C1V1 = C2V2
Related Product Recommendations
Please contact us with any specific requirements and we will get back to you as soon as possible.





